Leah Lawrence

US FDA recently approved rituximab biosimilar as monotherapy and in combination with chemotherapy.

A report on current legislation and practice trends regarding opioids and how they are affecting cancer patients’ ability to manage their pain.

Women with a history of breast cancer face a wide variety of challenges as they transition from the role of “patient” to “survivor”.